Form 4: ResMed CFO Earns Performance-Based Stock Units

ResMed's Chief Financial Officer, Brett Sandercock, acquired 5,462 shares of common stock through the earning of performance-based restricted stock units.

Summary

• Brett Sandercock, Chief Financial Officer of ResMed Inc. (RMD), acquired 5,462 shares of ResMed Common Stock.
• The acquisition occurred on August 15, 2025, when the compensation committee certified that performance metrics for previously granted restricted stock units were met.
• These shares were earned from performance-based restricted stock units granted on November 20, 2024.
• The shares were acquired at a price of $0, which is typical for the vesting or earning of restricted stock units.
• Following this transaction, Mr. Sandercock directly beneficially owns 88,745 shares of ResMed Common Stock.
• The stock units vest 1/3 each year on the anniversary of the grant.

Sentiment

Score: 7

Explanation: The sentiment is positive as the earning of performance-based shares indicates successful achievement of company performance metrics, aligning executive incentives with shareholder value.

Positives

• The earning of performance-based restricted stock units indicates that the company's performance metrics, as set by the compensation committee, were successfully met.
• This transaction increases the direct beneficial ownership of the Chief Financial Officer, aligning management's interests more closely with those of shareholders.
• The acquisition of shares through RSU vesting is a non-cash compensation event, which does not directly impact the company's cash flow.

Future Outlook

The filing does not provide specific forward-looking statements or guidance beyond the vesting schedule of the granted stock units.

Industry Context

This filing is a routine insider transaction related to executive compensation and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with shareholder value due to increased insider ownership and successful achievement of performance targets.
• Employees: Demonstrates the company's commitment to performance-based compensation for its executives.

Next Steps

• The remaining 2/3 of the performance-based restricted stock units are expected to vest annually on the anniversary of the grant date.

Key Dates

Recommendation

This Form 4 reports a routine compensation event (vesting of performance-based restricted stock units) for a key executive. While the successful achievement of performance metrics is a positive signal, it is not a new strategic announcement or a significant open-market purchase that would typically warrant a strong buy or sell recommendation. It reinforces a 'hold' position, indicating stable management alignment and execution against internal targets.

Keywords

ResMed, RMD, SEC Form 4, Insider Transaction, Restricted Stock Units, Performance-Based Compensation, Executive Compensation, Beneficial Ownership, CFO